DK1871400T3 - Uronsyre og probiotik - Google Patents

Uronsyre og probiotik

Info

Publication number
DK1871400T3
DK1871400T3 DK06733067.0T DK06733067T DK1871400T3 DK 1871400 T3 DK1871400 T3 DK 1871400T3 DK 06733067 T DK06733067 T DK 06733067T DK 1871400 T3 DK1871400 T3 DK 1871400T3
Authority
DK
Denmark
Prior art keywords
probiotics
uric acid
compositions
incidence
infection
Prior art date
Application number
DK06733067.0T
Other languages
English (en)
Inventor
Adrianus Johannes Maria Vriesema
Jan Knol
Bernd Stahl
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of DK1871400T3 publication Critical patent/DK1871400T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
DK06733067.0T 2005-04-21 2006-04-18 Uronsyre og probiotik DK1871400T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05103247A EP1714660A1 (en) 2005-04-21 2005-04-21 Uronic acid and probiotics
PCT/NL2006/050088 WO2006112714A2 (en) 2005-04-21 2006-04-18 Uronic acid and probiotics

Publications (1)

Publication Number Publication Date
DK1871400T3 true DK1871400T3 (da) 2012-01-23

Family

ID=34939437

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06733067.0T DK1871400T3 (da) 2005-04-21 2006-04-18 Uronsyre og probiotik

Country Status (12)

Country Link
US (1) US9168267B2 (da)
EP (3) EP1714660A1 (da)
CN (2) CN101163493A (da)
AT (1) ATE528012T1 (da)
AU (1) AU2006237736B2 (da)
CA (1) CA2605010A1 (da)
DK (1) DK1871400T3 (da)
ES (1) ES2374567T3 (da)
PL (1) PL1871400T3 (da)
PT (1) PT1871400E (da)
RU (2) RU2419445C2 (da)
WO (1) WO2006112714A2 (da)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2430881B (en) * 2005-10-06 2010-10-13 Ntnu Technology Transfer As Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
US20090156550A1 (en) * 2005-12-06 2009-06-18 Potappel-Van T Land Belinda Composition containing oligosaccharides for the treatment/prevention of infections
EP1800675B1 (en) 2005-12-23 2011-05-18 N.V. Nutricia Composition comprising polyunsaturated fatty acids, proteins, manganese and/or molybden and nucleosides/nucleotides for treating dementia
DK2164349T3 (da) * 2006-08-04 2014-12-15 Shs Int Ltd Proteinfri formel
WO2008115046A1 (en) * 2007-03-22 2008-09-25 N.V. Nutricia Cereal-based infant nutrition with fibre
GB0707096D0 (en) 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
ATE498325T1 (de) * 2007-07-06 2011-03-15 Nutricia Nv Verwendung von probiotika und ballaststoffen bei diarrhö
US10251899B2 (en) * 2007-10-08 2019-04-09 Mead Johnson Nutrition Company Method for improving stool characteristics in infants
CN101909636A (zh) * 2007-11-08 2010-12-08 雀巢产品技术援助有限公司 包含n-乙酰基乳糖胺的寡糖用于使新生儿免疫应答成熟的应用
WO2009067000A1 (en) * 2007-11-20 2009-05-28 N.V. Nutricia Composition with synbiotics
CA2706637C (en) 2007-11-27 2016-11-29 Algipharma Ipr As Use of alginate oligomers in combating biofilms
WO2009075564A1 (en) * 2007-12-10 2009-06-18 N.V. Nutricia Paediatric fibre mixture
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
WO2009102193A1 (en) * 2008-02-12 2009-08-20 N.V. Nutricia A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants
EP2130440A1 (en) * 2008-06-06 2009-12-09 N.V. Nutricia Inhibiting E. sakazakii growth
WO2010002241A1 (en) * 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
GB0904941D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
GB0904942D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
PL2437784T3 (pl) 2009-06-03 2014-04-30 Algipharma As Oligomery alginianu do stosowania w przezwyciężaniu oporności wielolekowej w bakteriach
GB0909529D0 (en) * 2009-06-03 2009-07-15 Algipharma Ipr As Alginate oligomers for the inhibition of microbial adherence to surfaces
BR112012000760B8 (pt) * 2009-07-15 2022-09-20 Nutricia Nv composição nutricional
CA2787544C (en) * 2010-01-28 2019-07-09 Ab-Biotics S.A. Probiotic composition for use in the treatment of bowel inflammation
WO2011149335A1 (en) * 2010-05-25 2011-12-01 N.V. Nutricia Immune imprinting nutritional composition
US9011909B2 (en) 2010-09-03 2015-04-21 Wisconsin Pharmacal Company, Llc Prebiotic suppositories
WO2012060718A1 (en) * 2010-11-05 2012-05-10 Sally Diana Poppitt Preventing or treating metabolic syndrome by administering a trans fatty acid, or a salt, ester or precursor thereof, or sialic acid in free or bound form
EP2452571A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of complementary infant/young child nutritional compositions
WO2012177556A2 (en) 2011-06-20 2012-12-27 H.J. Heinz Company Probiotic compositions and methods
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
PL3470074T3 (pl) 2013-05-10 2021-04-06 H.J. Heinz Company Brands Llc Probiotyki
WO2014200334A1 (en) * 2013-06-14 2014-12-18 N.V. Nutricia Synbiotic composition for treatment of infections in allergic patients
CN104413334A (zh) * 2013-08-30 2015-03-18 深圳华大基因科技有限公司 可食用组合物及其制备方法和用途
CA2942424C (en) * 2014-03-13 2019-12-31 Singapore Ze&Z International Pte. Ltd. Vaginal composition and use thereof
EP3400953A1 (en) 2014-12-23 2018-11-14 4D Pharma Research Limited Pirin polypeptide and immune modulation
SI3065748T1 (en) 2014-12-23 2018-05-31 4D Pharma Research Limited Severe bacteroid tethethioomycron and its use in reducing inflammation
CN108271354B (zh) 2015-06-15 2022-07-29 4D制药研究有限公司 包含细菌菌株的组合物
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PE20180242A1 (es) 2015-06-15 2018-01-31 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MX2017016529A (es) 2015-06-15 2018-03-12 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas.
MX2018002533A (es) * 2015-09-29 2018-06-27 Kimberly Clark Co Composicion sinergica para el mantenimiento de un equilibrio saludable de la microflora.
DK3209310T3 (da) 2015-11-20 2018-04-16 4D Pharma Res Ltd Sammensætninger omfattende bakteriestammer
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
EA035949B1 (ru) 2016-03-04 2020-09-04 4Д ФАРМА ПиЭлСи Применение композиции, содержащей бактериальный штамм вида blautia hydrogenotrophica, и способ лечения или предотвращения висцеральной гиперчувствительности
CN109561725A (zh) * 2016-06-10 2019-04-02 N·V·努特里奇亚 患过敏症的风险和用于降低该风险的营养物
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
TWI787272B (zh) 2017-05-22 2022-12-21 英商4D製藥研究有限公司 包含細菌菌株之組合物
WO2018215782A1 (en) 2017-05-24 2018-11-29 4D Pharma Research Limited Compositions comprising bacterial strain
SI3638271T1 (sl) 2017-06-14 2021-01-29 4D Pharma Research Limited Sestavki, ki vsebujejo bakterijske seve
DK3804737T3 (da) 2017-06-14 2022-07-25 4D Pharma Res Ltd Sammensætninger omfattende bakteriestammer
CA3068757A1 (en) 2017-07-05 2019-01-10 Evelo Biosciences, Inc. Compositions and methods of treating cancer using bifidobacterium animalis ssp. lactis
EP3530743A1 (en) 2018-02-21 2019-08-28 Cambridge Glycoscience Ltd Method of production
AU2019321182A1 (en) 2018-08-15 2021-03-11 Cambridge Glycoscience Ltd. Novel compositions, their use, and methods for their formation
CN109432136A (zh) * 2018-10-31 2019-03-08 张志澎 一种益生菌组合制剂及其制备方法和应用
CN110237092A (zh) * 2019-06-11 2019-09-17 厦门蓝特生物科技有限公司 一种治疗便秘的组合物
CN114727642A (zh) 2019-08-16 2022-07-08 剑桥糖质科学有限公司 处理生物质以生产寡糖的方法和相关组合物
WO2021116437A2 (en) 2019-12-12 2021-06-17 Cambridge Glycoscience Ltd Low sugar multiphase foodstuffs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741510A1 (fr) * 1995-11-27 1997-05-30 Standa Lab Sa Composition dietetique absorbable susceptible d'ameliorer l'equilibre biologique de la flore du tractus intestinal
EP1374878A1 (en) * 2002-06-20 2004-01-02 N.V. Nutricia Method and composition for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract
JP2004182609A (ja) * 2002-11-29 2004-07-02 Oji Paper Co Ltd 腸内環境改善剤
GB0308104D0 (en) 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
ES2314461T3 (es) * 2003-10-24 2009-03-16 N.V. Nutricia Composicion simbiotica para bebes.
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
PL1629850T5 (pl) * 2004-08-24 2013-09-30 Nutricia Nv Kompozycja odżywcza zawierająca niestrawne transgalaktooligosacharydy i strawne galaktozosacharydy

Also Published As

Publication number Publication date
CA2605010A1 (en) 2006-10-26
EP1871400B1 (en) 2011-10-12
WO2006112714A2 (en) 2006-10-26
EP1871400A2 (en) 2008-01-02
ATE528012T1 (de) 2011-10-15
RU2007143024A (ru) 2009-05-27
US9168267B2 (en) 2015-10-27
AU2006237736A1 (en) 2006-10-26
AU2006237736B2 (en) 2011-10-20
PT1871400E (pt) 2012-01-20
CN102670662A (zh) 2012-09-19
EP2353601B1 (en) 2015-09-23
ES2374567T3 (es) 2012-02-17
WO2006112714A3 (en) 2007-03-29
RU2419445C2 (ru) 2011-05-27
US20080199446A1 (en) 2008-08-21
PL1871400T3 (pl) 2012-02-29
RU2011101427A (ru) 2012-07-20
EP1714660A1 (en) 2006-10-25
EP2353601A1 (en) 2011-08-10
CN101163493A (zh) 2008-04-16

Similar Documents

Publication Publication Date Title
DK1871400T3 (da) Uronsyre og probiotik
NO20074941L (no) Anvendelse av diosmetinforbindelser i behandlingen og forebyggingen av trombotiske patologier
MX2011012067A (es) Leches para el crecimiento que contienen microorganismos probioticos.
TN2010000237A1 (en) Novel compounds and compositions and methods of use
MY191538A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
MY153039A (en) Thioacetate compounds,compositions and methods of use
PL2277524T3 (pl) Leczenie IBS z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia
NO20060350L (no) Spebarns- eller smabarnssammensetninger
MY162245A (en) Nutrition with non-viable bifidabacterium and non-digestible
MX2009009318A (es) Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.
DK1841756T3 (da) 3-heterocyclyl-3-hydroxy-2-amino-propionisyre-amider og relaterede forbindelser med analgesisk og/eller immunostimulatorisk aktivitet
PL1812023T3 (pl) Bakterie kwasu mlekowego jako szczepy probiotyczne i kompozycje je zawierające
MX2013005338A (es) Gama de formulas nutricionales adaptadas a la edad con probioticos.
DK1753440T3 (da) Oral administrationsform indeholdende probiotiske bakterier
MX2009011316A (es) Derivados del acido lipoico.
IL186217A0 (en) Anti-inflammatory modalities
MY168203A (en) Bioconversion of milk with bifidobacterium breve for treatment of allergic manifestations in infants
ZA201109086B (en) Prevention and treatment of allergic diarrhoea
ZA201102286B (en) Photosynthetic microorganisms enriched in selenium using selenohydroxy acid compounds, uses thereof in nutrition, cosmetics and oharmacy
MX2010002978A (es) Formulacion nutritiva con alto contenido energetico.
MD3417G2 (ro) Mediu nutritiv pentru cultivarea cianobacteriei Spirulina platensis
ATE410443T1 (de) Heterocyclyl-substituierte nonadepsipeptide
DE502005008925D1 (de) Substituierte nonadepsipeptide
ATE369142T1 (de) Nutrazeutische zusammensetzungen enthaltend milchenzyme als symbiose
JO2662B1 (en) Use of 4-methoxy-cyclopropyl-5, 3-N-dichloro-1-oxoperidine-4-yl-5 (methoxy) pyridine-2-carboxamide in the treatment of spinal cord injuries